Phantom GI Raises $5M for Minimally Invasive Ostomy
Phantom GI has raised $5M to develop a needle-based approach to ostomy creation that could avoid conventional surgery.

For frail patients, the procedure used to create an ostomy can itself carry significant clinical risk.
What happened
Phantom GI raised a $5 million seed round to advance PercStoma, a device designed to create an ostomy through a minimally invasive, needle-based procedure.
The approach is intended to avoid conventional surgery under general anaesthesia.
The device remains investigational and has not yet received regulatory approval.
Why it matters
Patients who need an ostomy are often already seriously ill or medically fragile.
Reducing the invasiveness of the procedure could lower physiological stress and potentially make treatment accessible to patients who are poor candidates for surgery.
The concept still needs clinical validation and regulatory approval.
The bigger picture
Medtech innovation increasingly focuses on converting surgical procedures into interventional ones.
That shift can reduce hospital stays, recovery time and procedural risk.
Phantom GI is applying that model to an area where the patient population may benefit particularly strongly from less invasive care.
